Recordati ups guidance on strong growth in specialty, primary care markets
Italian drug maker Recordati hiked its 2023 guidance on Thursday, as it posted first-quarter results showing solid growth for its specialty and primary care segments.... | May 11, 2023
Source: marketscreener.com